Feng is a Professor in the Department of Immunology and Immunity at Case Western University and a Staff Scientist at the Lerner Research Institute of the Cleveland Clinic. He has over 20 years of experience in studying immunology with more than 10 years of experience studying CD6 and its role in autoimmunity. This work led
Tony has co-founded and served as Vice President or President of eight different biotechnology companies. As an executive for these companies, he led four translational programs resulting in clinical trials, including the release into the marketplace of a medical food, SulfzixTM, for heart failure. He has initiated multiple licenses, oversaw build-out of facilities, hired staff